The present status of streptomycin in antimicrobial therapy.
D002701:Chloramphenicol / Q000627:therapeutic use; D003091:Colistin / Q000627:therapeutic use; D004096:Dihydrostreptomycin Sulfate / Q000009:adverse effects; D004357:Drug Synergism; D004698:Endocarditis, Subacute Bacterial / Q000188:drug therapy; D006311:Hearing Disorders / Q000139:chemically induced*; D006801:Humans; D007612:Kanamycin / Q000627:therapeutic use; D010403:Penicillin Resistance; D010406:Penicillins / Q000627:therapeutic use; D011113:Polymyxins / Q000627:therapeutic use; D018805:Sepsis / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy*; D013307:Streptomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use; D000159:Vestibulocochlear Nerve / Q000187:drug effects
D010406:Penicillins; D011113:Polymyxins; D007612:Kanamycin; D002701:Chloramphenicol; D013752:Tetracycline; D004096:Dihydrostreptomycin Sulfate; D013307:Streptomycin; D003091:Colistin